Key result
High pretransplant MELD scores are not associated with increased posttransplant ECMO use or early complications.
Why the study?
In advanced heart failure, congestion induces hepatic and renal dysfunction paralleling liver transplantation, and modified MELD scores (MELD-Na, MELD-XI) may improve applicability in heart transplantation.
Do pretransplant MELD-based scores (MELD > 20 vs <= 20) discriminate posttransplant ECMO use and early complications in heart transplantation recipients?
Cohort (n=379)
No
Do pretransplant MELD-based scores (MELD > 20 vs <= 20) discriminate posttransplant ECMO use and early complications in heart transplantation recipients?
Although MELD-XI offers broad applicability in anticoagulated heart transplant candidates and captures hepatorenal comorbidity, MELD-based scores did not significantly predict posttransplant ECMO use or early complications in this single-center cohort.
Answers are grounded in this paper and cite their sources.
MELD >20 does not support posttransplant risk stratification for ECMO or complications; leaves open utility of MELD-XI in heart transplant candidates.
All articles of this category (opens in new window) Background: The Model for End-Stage Liver Disease (MELD) score is the cornerstone of liver transplantation (LTX) allocation, predicting short-term mortality based on bilirubin, INR, and creatinine. In advanced heart failure, congestion induces hepatic and renal dysfunction, suggesting parallels to LTX. Modified scores (MELD-Na, MELD-XI) may improve applicability in heart transplantation (HTX). We analyzed MELD-based scores in a large single-center HTX cohort. Methods: We retrospectively reviewed 379 HTX recipients (2010–2025). MELD, MELD-Na, and MELD-XI were calculated from pretransplant laboratory values. Patients were stratified by MELD score ≤ 20 vs. >20. Posttransplant ECMO use and early complications were assessed. Results: MELD was calculable in 271 patients, MELD-Na in 183, and MELD-XI in 275 (72.6%), reflecting its practical applicability in anticoagulated patients. Median MELD was 15.3 [IQR: 10.9–19.5]; 22% had MELD > 20. High MELD (>20) patients had numerically higher ECMO use (34.4% vs. 33.0%) and complications (4.9% vs. 3.5%), but differences were not statistically significant ( p > 0.05). MELD-based scores nevertheless captured relevant hepatorenal dysfunction, with higher values reflecting more advanced comorbidity burden. Conclusion: MELD-based scores, established in liver allocation, are applicable in HTX and may help characterize hepatorenal dysfunction. In our cohort, MELD and MELD-Na did not significantly discriminate posttransplant ECMO use or early complications, whereas MELD-XI offered the broadest applicability due to frequent anticoagulation. While their prognostic impact appears limited, these scores may support comprehensive risk profiling in HTX candidates. Prospective multicenter studies are needed to clarify their role in patient selection and perioperative management. Publication History Article published online: 17 February 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
No takes yet. Share an insight, caveat, or question.
Phinicarides et al. (2026) conducted a cohort in Advanced heart failure undergoing heart transplantation (n=379). Pretransplant MELD score > 20 (and evaluation of MELD, MELD-Na, MELD-XI) vs. Pretransplant MELD score <= 20 was evaluated on Posttransplant ECMO use and early complications (p=>0.05). High pretransplant MELD (>20) was not associated with higher posttransplant ECMO use or early complications.
Synapse has enriched 10 related papers. Consider them for comparative context: